You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
拓新藥業(301089.SZ):精泉生物變更食品生產許可證
格隆匯 02-07 17:22

格隆匯2月7日丨拓新藥業(301089.SZ)公佈,公司全資子公司新鄉精泉生物技術有限公司(簡稱“精泉生物”)於近日收到河南省市場監督管理局頒發的《食品生產許可證》,同意公司《食品生產許可證》的變更申請,本次變更主要涉及新增5個產品的生產。

本次《食品生產許可證》新增1種其他食品L-α-甘磷酸膽鹼,該產品為2024年3月國家衞生健康委發佈的新食品原料;新增4種食品添加劑分別為5’-鳥苷酸二鈉、5’-肌苷酸二鈉、5’-單磷酸胞苷(5’-CMP)、5’-單磷酸尿苷,本次新增後,精泉生物實現了GB14880-2012《食品安全國家標準食品營養強化劑使用標準》中特殊膳食類核苷酸品種全覆蓋。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account